Zim Laboratories Limited has informed the Exchange about Acquisition
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zim Laboratories has completed an investment of Euro 3,00,000 (approximately ₹3.5 crore) into SIA ZIM Laboratories Limited, its wholly owned subsidiary based in Latvia (indicated by 'SIA', a Latvian company form). This follows the company's earlier announcement on 28 March 2025 about plans to invest up to Euro 4,00,000 in the same subsidiary. After this fresh capital infusion, Zim Labs continues to hold 100% of the subsidiary's total share capital, meaning ownership has not changed. The remaining Euro 1,00,000 of the originally announced commitment has not yet been deployed. The disclosure is being made under SEBI LODR Regulation 30.
This is a routine follow-on capital infusion into an existing wholly owned subsidiary rather than a new acquisition. No change in ownership or consolidation structure, so no material impact on shareholders or stock price is expected from this update alone.